The uncertain significance of low vitamin D levels in African descent populations: A review of the bone and cardiometabolic literature

Progress in Cardiovascular Diseases

Volumn 56, Issue 3, 2013, Pages 261-269

  O'Connor, Michelle Y ^a   Thoreson, Caroline K ^a   Ramsey, Natalie L M ^a   Ricks, Madia ^a   Sumner, Anne E ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

African Diaspora; African Americans; Africans; Lactose Intolerance; Melanin; Vitamin D

Indexed keywords

CALCIUM CARBONATE; COLECALCIFEROL; MELANIN; PLACEBO; VITAMIN D;

AFRICA; AFRICAN AMERICAN; ARTICLE; BONE METABOLISM; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CAUCASIAN; DIABETES MELLITUS; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG MEGADOSE; HUMAN; HYPERTENSION; IMMIGRANT; LACTOSE INTOLERANCE; LIFESTYLE MODIFICATION; LOW DRUG DOSE; NON INSULIN DEPENDENT DIABETES MELLITUS; RACE DIFFERENCE; SKIN PIGMENTATION; ULTRAVIOLET B RADIATION; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION;

AFRICAN DIASPORA; AFRICAN-AMERICANS; AFRICANS; BMD; BONE MINERAL DENSITY; FDA; FEDERAL DRUG ADMINISTRATION; INSTITUTE OF MEDICINE; IOM; LACTOSE INTOLERANCE; MELANIN; NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY; NHANES; PARATHYROID HORMONE; PTH; ULTRAVIOLET B; UVB; VDR; VITAMIN D; VITAMIN D RECEPTOR; WHI-OS; WOMEN'S HEALTH INITIATIVE-OBSERVATIONAL STUDY;

AFRICA; AFRICAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; HUMANS; MORBIDITY; OSTEOPOROSIS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84887875736     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2013.10.015     Document Type: Article

References (78)

1. Institute of Medicine: dietary reference intakes for calcium and vitamin D 2011, The National Academies Press.
2. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011, 96(7):1911-1930.
3. Norman A.W. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 2006, 147(12):5542-5548.
4. Jones G., Strugnell S.A., DeLuca H.F. Current understanding of the molecular actions of vitamin D. Physiol Rev 1998, 78(4):1193-1231.
5. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004, 80(6 Suppl):1689S-1696S.
6. Holick M.F. Vitamin D, deficiency. N Engl J Med 2007, 357(3):266-281.
7. 3 in humans. J Clin Endocrinol Metab 2004, 89(11):5387-5391.
8. 3 in healthy volunteers, a randomised placebo-controlled trial. J Clin Endocrinol Metab 2013, [in press].
9. Biancuzzo R.M., Young A., Bibuld D., et al. Fortification of orange juice with vitamin D(2) or vitamin D(3) is as effective as an oral supplement in maintaining vitamin D status in adults. Am J Clin Nutr 2010, 91(6):1621-1626.
10. Calvo M.S., Whiting S.J., Barton C.N. Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr 2004, 80(6 Suppl):1710S-1716S.
11. Tangpricha V., Koutkia P., Rieke S.M., Chen T.C., Perez A.A., Holick M.F. Fortification of orange juice with vitamin D: a novel approach for enhancing vitamin D nutritional health. Am J Clin Nutr 2003, 77(6):1478-1483.
12. Hewison M., Zehnder D., Chakraverty R., Adams J.S. Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase. Mol Cell Endocrinol 2004, 215(1-2):31-38.
13. Li J., Byrne M.E., Chang E., et al. 1Alpha,25-dihydroxyvitamin D hydroxylase in adipocytes. J Steroid Biochem Mol Biol 2008, 112(1-3):122-126.
14. 3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 2005, 111(13):1666-1671.
15. 3 through C-24 oxidation pathway. Biochemistry 1989, 28(4):1763-1769.
16. Armas L.A., Dowell S., Akhter M., et al. Ultraviolet-B radiation increases serum 25-hydroxyvitamin D levels: the effect of UVB dose and skin color. J Am Acad Dermatol 2007, 57(4):588-593.
17. Black L.J., Seamans K.M., Cashman K.D., Kiely M. An updated systematic review and meta-analysis of the efficacy of vitamin D food fortification. J Nutr 2012, 142(6):1102-1108.
18. Byers K.G., Savaiano D.A. The myth of increased lactose intolerance in African-Americans. J Am Coll Nutr 2005, 24(6 Suppl):569S-573S.
19. Sahi T. Genetics and epidemiology of adult-type hypolactasia. Scand J Gastroenterol Suppl 1994, 202:7-20.
20. Vesa T.H., Marteau P., Korpela R. Lactose intolerance. J Am Coll Nutr 2000, 19(2 Suppl):165S-175S.
21. Jarvis J.K., Miller G.D. Overcoming the barrier of lactose intolerance to reduce health disparities. J Natl Med Assoc 2002, 94(2):55-66.
22. Nicklas T.A., Qu H., Hughes S.O., et al. Self-perceived lactose intolerance results in lower intakes of calcium and dairy foods and is associated with hypertension and diabetes in adults. Am J Clin Nutr 2011, 94(1):191-198.
23. Wolf G. The discovery of vitamin D: the contribution of Adolf Windaus. J Nutr 2004, 134(6):1299-1302.
24. Rosen C.J., Adams J.S., Bikle D.D., et al. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev 2012, 33(3):456-492.
25. Aloia J.F. African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox. Am J Clin Nutr 2008, 88(2):545S-550S.
26. Freedman B.I., Register T.C. Effect of race and genetics on vitamin D metabolism, bone and vascular health. Nat Rev Nephrol 2012, 8(8):459-466.
27. Ganji V., Zhang X., Tangpricha V. Serum 25-hydroxyvitamin D concentrations and prevalence estimates of hypovitaminosis D in the U.S. population based on assay-adjusted data. J Nutr 2012, 142(3):498-507.
28. Gutierrez O.M., Farwell W.R., Kermah D., Taylor E.N. Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos Int 2011, 22(6):1745-1753.
29. Kant A.K., Graubard B.I. Race-ethnic, family income, and education differentials in nutritional and lipid biomarkers in US children and adolescents: NHANES 2003-2006. Am J Clin Nutr 2012, 96(3):601-612.
30. Looker A.C., Pfeiffer C.M., Lacher D.A., Schleicher R.L., Picciano M.F., Yetley E.A. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008, 88(6):1519-1527.
31. Aspray T.J., Yan L., Prentice A. Parathyroid hormone and rates of bone formation are raised in perimenopausal rural Gambian women. Bone 2005, 36(4):710-720.
32. Charlton K.E., Labadarios D., Lombard C.J., Louw M.E. Vitamin D status of older South Africans. S Afr Med J 1996, 86(11):1406-1410.
33. Daniels E.D., Pettifor J.M., Schnitzler C.M., Moodley G.P., Zachen D. Differences in mineral homeostasis, volumetric bone mass and femoral neck axis length in black and white South African women. Osteoporos Int 1997, 7(2):105-112.
34. Dibba B., Prentice A., Laskey M.A., Stirling D.M., Cole T.J. An investigation of ethnic differences in bone mineral, hip axis length, calcium metabolism and bone turnover between West African and Caucasian adults living in the United Kingdom. Ann Hum Biol 1999, 26(3):229-242.
35. Emilion E., Emilion R. Estimation of the 25(OH) vitamin D threshold below which secondary hyperparathyroidism may occur among African migrant women in Paris. Int J Vitam Nutr Res 2011, 81(4):218-224.
36. Kruger M.C., Kruger I.M., Wentzel-Viljoen E., Kruger A. Urbanization of black South African women may increase risk of low bone mass due to low vitamin D status, low calcium intake, and high bone turnover. Nutr Res 2011, 31(10):748-758.
37. Luxwolda M.F., Kuipers R.S., Kema I.P., Dijck-Brouwer D.A., Muskiet F.A. Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115nmol/l. Br J Nutr 2012, 108(9):1557-1561.
38. Njemini R., Meyers I., Demanet C., Smitz J., Sosso M., Mets T. The prevalence of autoantibodies in an elderly sub-Saharan African population. Clin Exp Immunol 2002, 127(1):99-106.
39. Prentice A., Jarjou L.M., Goldberg G.R., Bennett J., Cole T.J., Schoenmakers I. Maternal plasma 25-hydroxyvitamin D concentration and birthweight, growth and bone mineral accretion of Gambian infants. Acta Paediatr 2009, 98(8):1360-1362.
40. Reed S.D., Laya M.B., Melville J., Ismail S.Y., Mitchell C.M., Ackerman D.R. Prevalence of vitamin D insufficiency and clinical associations among veiled East African women in Washington State. J Womens Health (Larchmt) 2007, 16(2):206-213.
41. van der Meer I.M., Boeke A.J., Lips P., et al. Fatty fish and supplements are the greatest modifiable contributors to the serum 25-hydroxyvitamin D concentration in a multiethnic population. Clin Endocrinol (Oxf) 2008, 68(3):466-472.
42. Barrett-Connor E., Siris E.S., Wehren L.E., et al. Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res 2005, 20(2):185-194.
43. Aloia J.F., Vaswani A., Yeh J.K., Flaster E. Risk for osteoporosis in black women. Calcif Tissue Int 1996, 59(6):415-423.
44. Cauley J.A., Lui L.Y., Ensrud K.E., et al. Bone mineral density and the risk of incident nonspinal fractures in black and white women. JAMA 2005, 293(17):2102-2108.
45. Araujo A.B., Travison T.G., Harris S.S., Holick M.F., Turner A.K., McKinlay J.B. Race/ethnic differences in bone mineral density in men. Osteoporos Int 2007, 18(7):943-953.
46. Hannan M.T., Litman H.J., Araujo A.B., et al. Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men. J Clin Endocrinol Metab 2008, 93(1):40-46.
47. Tracy J.K., Meyer W.A., Flores R.H., Wilson P.D., Hochberg M.C. Racial differences in rate of decline in bone mass in older men: the Baltimore men's osteoporosis study. J Bone Miner Res 2005, 20(7):1228-1234.
48. Aspray T.J., Prentice A., Cole T.J., Sawo Y., Reeve J., Francis R.M. Low bone mineral content is common but osteoporotic fractures are rare in elderly rural Gambian women. J Bone Miner Res 1996, 11(7):1019-1025.
49. Adebajo A.O., Cooper C., Evans J.G. Fractures of the hip and distal forearm in West Africa and the United Kingdom. Age Ageing 1991, 20(6):435-438.
50. Cauley J.A., Danielson M.E., Boudreau R., et al. Serum 25-hydroxyvitamin D and clinical fracture risk in a multiethnic cohort of women: the Women's Health Initiative (WHI). J Bone Miner Res 2011, 26(10):2378-2388.
51. Freedman B.I., Wagenknecht L.E., Hairston K.G., et al. Vitamin d, adiposity, and calcified atherosclerotic plaque in African-Americans. J Clin Endocrinol Metab 2010, 95(3):1076-1083.
52. Bell N.H., Greene A., Epstein S., Oexmann M.J., Shaw S., Shary J. Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest 1985, 76(2):470-473.
53. Cosman F., Morgan D.C., Nieves J.W., et al. Resistance to bone resorbing effects of PTH in black women. J Bone Miner Res 1997, 12(6):958-966.
54. Cosman F., Shen V., Morgan D., et al. Biochemical responses of bone metabolism to 1,25-dihydroxyvitamin D administration in black and white women. Osteoporos Int 2000, 11(3):271-277.
55. Elamin M.B., Abu Elnour N.O., Elamin K.B., et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011, 96(7):1931-1942.
56. George P.S., Pearson E.R., Witham M.D. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med 2012, 29(8):e142-e150.
57. Pittas A.G., Chung M., Trikalinos T., et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 2010, 152(5):307-314.
58. Song Y., Wang L., Pittas A.G., et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 2013, 36(5):1422-1428.
59. Blum M., Dolnikowski G., Seyoum E., et al. Vitamin D(3) in fat tissue. Endocrine 2008, 33(1):90-94.
60. Coney P., Demers L.M., Dodson W.C., Kunselman A.R., Ladson G., Legro R.S. Determination of vitamin D in relation to body mass index and race in a defined population of black and white women. Int J Gynaecol Obstet 2012, 119(1):21-25.
61. Yanoff L.B., Parikh S.J., Spitalnik A., et al. The prevalence of hypovitaminosis D and secondary hyperparathyroidism in obese Black Americans. Clin Endocrinol (Oxf) 2006, 64(5):523-529.
62. Rock C.L., Emond J.A., Flatt S.W., et al. Weight loss is associated with increased serum 25-hydroxyvitamin D in overweight or obese women. Obesity (Silver Spring) 2012, 20(11):2296-2301.
63. Scragg R., Sowers M., Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004, 27(12):2813-2818.
64. Pittas A.G., Nelson J., Mitri J., et al. Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program. Diabetes Care 2012, 35(3):565-573.
65. Robinson J.G., Manson J.E., Larson J., et al. Lack of association between 25(OH)D levels and incident type 2 diabetes in older women. Diabetes Care 2011, 34(3):628-634.
66. Harris S.S., Pittas A.G., Palermo N.J. A randomized, placebo-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans. Diabetes Obes Metab 2012, 14(9):789-794.
67. Davidson M.B., Duran P., Lee M.L., Friedman T.C. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care 2013, 36(2):260-266.
68. Fiscella K., Franks P. Vitamin D, race, and cardiovascular mortality: findings from a national US sample. Ann Fam Med 2010, 8(1):11-18.
69. Gupta A.K., Brashear M.M., Johnson W.D. Low vitamin D levels, prediabetes and prehypertension in healthy African American adults. Nutr Metab Cardiovasc Dis 2012, 22(10):877-882.
70. Schmitz K.J., Skinner H.G., Bautista L.E., et al. Association of 25-hydroxyvitamin D with blood pressure in predominantly 25-hydroxyvitamin D deficient Hispanic and African Americans. Am J Hypertens 2009, 22(8):867-870.
71. Scragg R., Sowers M., Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 2007, 20(7):713-719.
72. Witham M.D., Nadir M.A., Struthers A.D. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens 2009, 27(10):1948-1954.
73. Forman J.P., Scott J.B., Ng K., et al. Effect of vitamin D supplementation on blood pressure in blacks. Hypertension 2013, 61(4):779-785.
74. 3 supplementation for 16weeks improves flow-mediated dilation in overweight African-American adults. Am J Hypertens 2011, 24(5):557-562.
75. Margolis K.L., Ray R.M., Van Horn L., et al. Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial. Hypertension 2008, 52(5):847-855.
76. Michos E.D., Reis J.P., Post W.S., et al. 25-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: The NHANES-III linked mortality files. Nutrition 2012, 28(4):367-371.
77. Robinson-Cohen C., Hoofnagle A.N., Ix J.H., et al. Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA 2013, 310(2):179-188.
78. Norris K.C., Williams S.F. Race/ethnicity, serum 25-hydroxyvitamin D, and heart disease. JAMA 2013, 310(2):153-155.